Kelvin Moses MD, PhD
Medical School: Baylor College of Medicine, Houston, TX
Residency: Emory University School of Medicine, Atlanta, GA
Fellowship: Memorial Sloan-Kettering Cancer Center, New York, NY
Clinical Interests: Advanced Prostate Cancer, Advanced Kidney Cancer, Testis Cancer, Penile Cancer, Adrenal Cancer
Dr. Moses is the Director of the Comprehensive Prostate Cancer clinic and Director of the Urologic Oncology Fellowship. He is the Chair of the NCCN Guidelines Panel on Early Detection of Prostate Cancer. His surgical practice focuses on advanced kidney cancer, including complex IVC thrombectomy and cytoreductive nephrectomy, and advanced testis cancer via retroperitoneal lymph node dissection. He has research interests in health literacy and cancer outcomes, advanced prostate cancer clinical trials, and optimal surgical resection for advanced Urologic cancers.
Active Clinical Trials
Janssen
Neo-adjuvant and adjuvant apalutamide/placebo plus ADT in Subjects with High-risk, Localized or Locally Advanced Prostate Cancer Who are Candidates for Radical Prostatectomy
Myriad Prolaris
Long-Term Prospective Registry in Prostate Cancer Patients from Diverse Urology Practice Settings Following Prolaris Testing
DAROL
A Study in Which Non-metastatic Castration-Resistant Prostate Cancer (nmCRPC) Patients for Whom a Decision to Treat with Darolutamide has been Made Before Enrollment are Observed and Certain Outcomes are Described